RecruitingNot ApplicableNCT06887049

Achieving Routine Intervention and Screening for Emotional Health

ARISE: Achieving Routine Intervention and Screening for Emotional Health: Randomized Controlled Trial

Sponsor

University of Chicago

Enrollment

1,250 participants

Start Date

Mar 3, 2026

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes Mellitus (T2DM)Diabetes Distress

Summary

The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to improve emotional health screening for adults with type 2 diabetes who have poorly controlled blood sugar. Many people with diabetes also struggle with depression or anxiety, and this study tests whether routine emotional health check-ins at the clinic can make a difference. **You may be eligible if...** - You are an adult (18 or older) - You are a patient at a participating clinic - You have type 2 diabetes - Your A1C (a blood sugar control measure) is above 8% **You may NOT be eligible if...** - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALARISE Learning Community Diabetes Distress Screening and Intervention

In-depth training for frontline community health center staff on ARISE algorithm to screen for degree of diabetes distress using T2-DDAS Core. If positive, screen for sources of diabetes distress using T2-DDAS Sources. Discuss results with patient and make any relevant referrals.

BEHAVIORALARISE Enhanced Care brief training

Brief training on American Diabetes Association guidelines for screening for diabetes distress using the 7A's model

Locations(1)

University of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06887049

Related Trials

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT066138541 location

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

NCT068213993 locations

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

NCT0684520220 locations

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

NCT074652241 location

Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers

NCT075335391 location